Rise Advisors LLC lowered its stake in The Procter & Gamble Company (NYSE:PG – Free Report) by 22.4% during the fourth quarter, Holdings Channel.com reports. The fund owned 1,655 shares of the company’s stock after selling 478 shares during the period. Rise Advisors LLC’s holdings in Procter & Gamble were worth $278,000 as of its most recent SEC filing.
Other large investors have also recently bought and sold shares of the company. Itau Unibanco Holding S.A. bought a new stake in shares of Procter & Gamble during the 2nd quarter worth approximately $28,000. Fairway Wealth LLC bought a new stake in Procter & Gamble during the second quarter worth $29,000. RPg Family Wealth Advisory LLC acquired a new stake in Procter & Gamble in the third quarter valued at $33,000. Quest Partners LLC acquired a new position in shares of Procter & Gamble during the 2nd quarter worth about $36,000. Finally, Fairfield Financial Advisors LTD bought a new stake in shares of Procter & Gamble in the 2nd quarter valued at about $44,000. 65.77% of the stock is owned by institutional investors and hedge funds.
Procter & Gamble Trading Up 0.4 %
PG stock traded up $0.70 during midday trading on Tuesday, hitting $161.30. The stock had a trading volume of 4,063,602 shares, compared to its average volume of 5,820,512. The company has a current ratio of 0.75, a quick ratio of 0.55 and a debt-to-equity ratio of 0.50. The firm has a market cap of $379.87 billion, a P/E ratio of 27.81, a price-to-earnings-growth ratio of 3.70 and a beta of 0.45. The business has a fifty day moving average price of $170.03 and a two-hundred day moving average price of $169.80. The Procter & Gamble Company has a 1-year low of $146.28 and a 1-year high of $180.43.
Analysts Set New Price Targets
A number of brokerages have weighed in on PG. Hsbc Global Res raised Procter & Gamble to a “strong-buy” rating in a research report on Friday, October 4th. DA Davidson restated a “buy” rating and issued a $209.00 price target on shares of Procter & Gamble in a research note on Friday, December 27th. Morgan Stanley lifted their price objective on shares of Procter & Gamble from $174.00 to $191.00 and gave the stock an “overweight” rating in a research report on Monday, October 21st. Evercore ISI increased their price objective on shares of Procter & Gamble from $180.00 to $183.00 and gave the company an “outperform” rating in a research report on Monday, October 21st. Finally, Royal Bank of Canada reaffirmed a “sector perform” rating and set a $164.00 target price on shares of Procter & Gamble in a report on Monday, October 21st. Eight investment analysts have rated the stock with a hold rating, fourteen have given a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $179.75.
Check Out Our Latest Stock Analysis on Procter & Gamble
Insider Activity at Procter & Gamble
In other news, CEO Gary A. Coombe sold 47,847 shares of the company’s stock in a transaction dated Wednesday, November 27th. The shares were sold at an average price of $179.84, for a total transaction of $8,604,804.48. Following the transaction, the chief executive officer now owns 39,977 shares in the company, valued at approximately $7,189,463.68. This represents a 54.48 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO R. Alexandra Keith sold 1,992 shares of the firm’s stock in a transaction dated Tuesday, October 22nd. The shares were sold at an average price of $170.00, for a total value of $338,640.00. Following the completion of the sale, the chief executive officer now owns 13,783 shares of the company’s stock, valued at approximately $2,343,110. This represents a 12.63 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 75,439 shares of company stock worth $13,317,460 in the last quarter. Company insiders own 0.18% of the company’s stock.
Procter & Gamble Profile
The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.
Featured Articles
- Five stocks we like better than Procter & Gamble
- Industrial Products Stocks Investing
- Disney: Forging a 3-Headed Sports Streaming Giant With Fubo Deal
- Upcoming IPO Stock Lockup Period, Explained
- How Buffett’s Best and Worst Stock Bets Have Fared 5 Years Later
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Bill Ackman’s Bold Case for Fannie Mae and Freddie Mac
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.